FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileBiotron Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
BIT.AX
Biotron Limited Stock AnalysisComprehensive stock analysis for Biotron Limited (BIT.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisBIT.AX
BIT.AX
Biotron Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
BIT.AX
  1. Home
  2. Stocks
  3. Biotron Limited

Biotron Limited

🇦🇺BIT.AX•ASX

Biotron Limited

🇦🇺BIT.AX•ASX

Your view on BIT.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Biotron Limited

Industry
Biotechnology
Sector
Healthcare
CEO
Michelle Miller GCertAppFin
Headquarters
66 Hunter Street, Sydney, NSW, AU
Industry
Biotechnology
Sector
Healthcare
CEO
Michelle Miller GCertAppFin
Headquarters
66 Hunter Street, Sydney, NSW, AU
Description

Biotron Limited is an Australian biotechnology firm dedicated to the creation and market introduction of small molecule therapies designed to combat a range of viral illnesses.

Its flagship antiviral compound, BIT225, is currently undergoing Phase II clinical evaluations for addressing infections caused by SARS-CoV-2, HIV-1, and the hepatitis C virus. Established in 1999, the company operates from its main office in Sydney, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Biotron Limited. Starting points for Biotron Limited: beta -0.61 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Biotron Limited. Biotron Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Biotron Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Biotron Limited. Biotron Limited has reported as a listed company since 2001. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold BIT.AX19 companies
Compare BIT.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
1AD.AXAdAlta LimitedHealthcareBiotechnology—
ACR.AXAcrux LimitedHealthcareBiotechnology—
ADR.AXAdherium LimitedHealthcareMedical - Devices—
BGT.AXBio-Gene Technology LimitedBasic MaterialsAgricultural Inputs—
CHM.AXChimeric Therapeutics LimitedHealthcareBiotechnology—
GLH.AXGlobal Health LimitedHealthcareMedical - Care Facilities—
IBX.AXImagion Biosystems LimitedHealthcareMedical - Diagnostics & Research—
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
OVIDOvid Therapeutics Inc.HealthcareNASDAQ$426.5M
OXBOFOxford BioDynamics PlcHealthcareOTC$4.3M
OZYMFStrategic Partners A/SHealthcareOTC$3.7M
PAB.AXPatrys LimitedHealthcareASX—
PALIPalisade Bio, Inc.HealthcareNASDAQ$168.9M
PANCPanacos Pharmaceuticals, Inc.HealthcareOTC$5,367
PAR.AXParadigm Biopharmaceuticals LimitedHealthcareASX—
PARDPoniard Pharmaceuticals, Inc.HealthcareOTC$150
PASGPassage Bio, Inc.HealthcareNASDAQ$12.9M
PBIGFParadigm Biopharmaceuticals LimitedHealthcareOTC$87.9M
PBLAPanbela Therapeutics, Inc.HealthcareOTC$53,889
PBLSParabilis Medicines, Inc.HealthcareNASDAQ$3.5B
Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Biotron Limited.

BIT.AX AnalysisWeak
Past
1
Growth
1
Health
5
Profit
1
Value
1